As a dual GIP/GLP-1 receptor agonist, Tirzepatide may help increase insulin sensitivity, reduce body fat, stabilize glucose levels
In a recent study published in Ophthalmology, researchers found that GLP-1 weight loss drugs like Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy in people with type 2 diabetes
In short, it is a personalization strategy, not a formally validated alternative to labeled dosing
Mistake 4: using the wrong syringe type We covered TB syringes earlier, but there is another issue
It will depend on how your body reacts to the medication in terms of weight loss or blood sugar management, balanced against side effects
The response is still individual, but the dual-incretin design appears to enhance fat loss for many patients